Illumina Researcher Outlines Strategy for Interpreting Clinical Information in Healthy Genomes | GenomeWeb

By Andrea Anderson

VANCOUVER, BRITISH COLUMBIA (GenomeWeb News) – At the American College of Medical Genetics annual meeting here this week, Illumina UK researcher Mark Ross discussed strategies that Illumina researchers are using to interpret information in genome sequences from healthy individuals generated through the company's clinical whole-genome sequencing service.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.